Skip to content
Chat on WhatsApp
RTT60

Incretin-Pathway Peptides

RTT60

Retatrutide and tirzepatide combined at a defined nominal mass ratio, sealed as a lyophilized vial for comparative research.

  • Retatrutide and tirzepatide combined
  • Nominal mass ratio in batch documentation
  • Sealed vial, 60mg total

Research use only

RTT60 combines retatrutide and tirzepatide at a defined nominal mass ratio in a single lyophilized vial. It sits in the incretin-pathway section as a two-component counterpart to the single-molecule retatrutide and tirzepatide entries.

This blend is intended for controlled in-vitro comparison between the two components, analytical characterization of the combined preparation, and component-compatibility research. Because it is a two-peptide blend, the exact mass ratio and any single molecular identifier are set out per batch in the documentation rather than on this page.

The vial is sealed after freeze-drying and labeled with a total nominal mass of 60mg. Batch documentation is confirmed by inquiry.

Purity≥99% by HPLC
CAS numberSee batch documentation
Molecular weightSee batch documentation
Molecular formulaSee batch documentation
Material classTwo-component peptide blend
AppearanceWhite to off-white lyophilized powder
Available vial sizes60mg total
DocumentationBatch documentation confirmed on request

← Back to the catalog